Literature DB >> 2050923

Evaluation and management of patients with both peripheral vascular and coronary artery disease.

B J Gersh1, C S Rihal, T W Rooke, D J Ballard.   

Abstract

The prevalence of serious angiographic coronary artery disease ranges from 37% to 78% in patients undergoing operation for peripheral vascular disease. Clinical studies have demonstrated that cardiac outcome after peripheral vascular surgery is not adequately predicted by the standard criteria of history, physical findings and rest electrocardiogram. An adequate exercise work load, left ventricular function and thallium redistribution have proved important in perioperative risk stratification. The choice of a perioperative functional cardiac test depends on patient-related factors and the nature of the peripheral vascular operation. Although procedures involving aortic cross-clamping exert a greater hemodynamic stress than do carotid endarterectomy and femoral popliteal surgery, late cardiac morbidity and mortality are significant in all patients with atherosclerotic disease. The decision to proceed with preoperative coronary angiography and myocardial revascularization should be based primarily on indications independent of the peripheral vascular procedure. However, peripheral vascular surgery may influence the timing of myocardial revascularization. Patients with high risk or unstable coronary artery disease may benefit from preoperative coronary revascularization, although this hypothesis remains unproved. In all patients, careful monitoring during and after operation is essential. All patients with peripheral vascular disease should be considered to be at lifelong risk for fatal and nonfatal cardiac events and should undergo appropriate clinical and laboratory evaluation and be treated accordingly.

Entities:  

Mesh:

Year:  1991        PMID: 2050923     DOI: 10.1016/s0735-1097(10)80241-4

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  13 in total

1.  Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association.

Authors: 
Journal:  Heart       Date:  1998-12       Impact factor: 5.994

Review 2.  The question: to test or not to test in preoperative cardiac risk evaluation.

Authors:  J A Leppo; S T Dahlberg
Journal:  J Nucl Cardiol       Date:  1998 May-Jun       Impact factor: 5.952

3.  Multisystem revascularization.

Authors:  Zehra Jaffery; Arthur Grant
Journal:  Ochsner J       Date:  2009

4.  Preoperative cardiac risk assessment for noncardiac surgery.

Authors:  J A Leppo
Journal:  J Nucl Cardiol       Date:  1995 Sep-Oct       Impact factor: 5.952

Review 5.  Frequency of coronary artery disease in patients undergoing peripheral artery disease surgery.

Authors:  David J Hur; Muhammed Kizilgul; Wai W Aung; Kristin C Roussillon; Ellen C Keeley
Journal:  Am J Cardiol       Date:  2012-05-24       Impact factor: 2.778

Review 6.  Prognosis after graft replacement operation for abdominal aortic aneurysm.

Authors:  J Feinglass; W H Pearce; G J Martin
Journal:  West J Med       Date:  1993-10

7.  Apolipoprotein (a) concentrations and susceptibility to coronary artery disease in patients with peripheral vascular disease.

Authors:  P Groves; A Rees; A Bishop; R Morgan; M Ruttley; N Lewis; I Lane; R Hall
Journal:  Br Heart J       Date:  1993-01

Review 8.  Cardiac evaluation and risk reduction in patients undergoing major vascular operations.

Authors:  D K Potyk
Journal:  West J Med       Date:  1994-07

Review 9.  Intermittent claudication in older patients. Practical treatment guidelines.

Authors:  H Boccalon
Journal:  Drugs Aging       Date:  1999-04       Impact factor: 3.923

10.  The diagnosis and perioperative management of myocardial ischaemia.

Authors:  C D Mazer
Journal:  Can J Anaesth       Date:  1992-05       Impact factor: 5.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.